Anti-muc-1 single chain antibodies for tumor targeting
CA 2443138 A1 · Owner: The Regents Of The University Of California · Inventors: Winthrop, Michelle Denise; Denardo, Gerald Louis; Denardo, Sally Joan
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention provides novel antibodies that specifically bind to the cancer antigen MUC-1. The antibodies are useful targeting moieties for specifically directing imaging agents and various thereapeutic moieties to a cancer.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 28, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 28, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 28, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.